A market cap of $400M is where this company should be today. One approved drug and another one on July 26th. $16 on approval day, $550M market cap is about right. With the projected sales, the partnerships, potential acquisition, the strong balance sheet, the ever-improving EPS, this mid-cap company is as good as it gets. Enjoy it folks.
Spammers/shorts/bashers - this is the wrong stock to short or bash unless you want to get burnt.